Success Showcase: 【Guotai Guomian】Highlights Integrated API Solutions at FCE-PHARMA 2025

Strengthening Latin American Partnerships Through End-to-End Pharmaceutical Supply Chain Expertise

São Paulo, Brazil – June 18, 2025– [Guotai Guomian], a global provider of integrated pharmaceutical supply chain solutions and compliance services, successfully concluded its participation at FCE-PHARMA 2025, Latin America’s largest pharmaceutical ingredients and technology exhibition held from June 10-12 at São Paulo Expo.

Strategic Presence in Key Growth Market

With nearly two decades of market commitment in Latin America, [Guotai Guomian] co-hosted its exhibition booth with long-term Brazilian partner COPERMED, showcasing its full-spectrum capabilities:

✅ Specialized API Supply (Cardiovascular, Anti-infectives, CNS, etc)
✅ Regulatory Compliance Support
✅ Global Supply Chain Optimization

Driving Client Engagement & Expansion

Over three days, our technical-commercial team conducted 50+ meetings with established and prospective partners across Brazil, Argentina, Mexico, and Colombia,etc. Key outcomes included:

🔹 Enhanced Strategic Alliances with top-tier clients
🔹 4 new project opportunities in novel drug formulations
🔹 Market validation for compliance-driven supply models

"This exhibition reaffirms Latin America’s critical role in global pharmaceutical growth," noted [Deputy G.M. /Daniel Chen]." Our integrated ‘API + Compliance + Logistics’ approach directly addresses regional needs for quality-driven, agile supply chains."

Commitment to Sustainable Health Solutions

Building on FCE-PHARMA engagements, [Guotai Guomian] will:

• Accelerate local regulatory filings for 2 high-demand APIs
  
• Establish technical consulting team in Q4 2025 providing process optimization, impurity profiling, and technical support services.
  
• Expand APIs distribution capabilities across Mercosur

【Jiangsu Guotai】team discusses GMP compliance requirements with Brazilian partners at FCE-PHARMA 2025